The Relationship between Chlamydia pneumoniae Seropositivity and Peripheral Vascular Diseases, Acute Myocardial Infarction and Late-Onset Asthma [2]

Infection

Volumn 31, Issue 5, 2003, Pages 367-368

  Sirmatel, F ^a   Ustunsoy, H ^a   Sirmatel, O ^b   Akdemir, I ^a   Dikensoy, O ^a  

^a GAZIANTEP UNIVERSITY   (Turkey)

^b HARRAN UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; BRONCHODILATING AGENT; CREATINE KINASE; ISOENZYME; LIPID;

ACUTE HEART INFARCTION; ADULT; AGED; ANAMNESIS; ANTIBODY SPECIFICITY; ANTIBODY TITER; ASTHMA; ATHEROSCLEROSIS; BLOOD SAMPLING; CHLAMYDOPHILA PNEUMONIAE; CLINICAL FEATURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DILUTION; DISEASE MARKER; DOPPLER ECHOGRAPHY; ELECTROCARDIOGRAM; ENZYME ACTIVITY; FEMALE; HIGH RISK POPULATION; HOSPITAL DEPARTMENT; HOSPITAL PATIENT; HUMAN; HYPERCHOLESTEROLEMIA; IMMUNOFLUORESCENCE; LABORATORY TEST; LETTER; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NONHUMAN; ONSET AGE; PERIPHERAL VASCULAR DISEASE; RISK ASSESSMENT; SEROLOGY; SMOKING HABIT; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STUDENT T TEST; TURKEY (REPUBLIC);

EID: 0141887473     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-003-2130-9     Document Type: Letter

References (9)

1. Smieja M, Mahony J, Petrich A, Boman J, Chernesky M: Association of circulating Chlamydia pneumoniae DNA with cardiovascular disease: a systematic review. BMC Infect Dis 2002; 2: 21.
2. Falck G, Gnarpe J, Hansson LO, Svardsudd K, Gnarpe H: Comparison of individuals with and without specific IgA antibodies to Chlamydia pneumoniae: respiratory morbidity and the metabolic syndrome. Chest 2002; 122: 1587-1593.
3. Airenne S, Surcel HM, Alakarppa H, Laitinen K, Paavonen J, Saikku P, Laurila A: Chlamydia pneumoniae infection in human monocytes. Infect Immun 1999; 67: 1445-1449.
4. Saikku P, Leinonen M, Matilla K: Serological evidence of an association of a novel Chlamydia pneumoniae (TWAR) with chronic coronary heart disease and acute myocardial infarction. Lancet 1988; 2: 983-986.
5. Hahn DL, Peeling RW, Dillon E, McDonald R, Saikku P: Serologic markers for Chlamydia pneumoniae in asthma. Ann Allergy Asthma Immunol 2000; 84: 227-233.
6. Gencay M, Rudiger JJ, Tamm M, Soler M, Perruchoud AP, Roth M: Increased frequency of Chlamydia pneumoniae antibodies in patients with asthma. Am J Respir Crit Care Med 2001; 163: 1097-1100.
7. Wang SP: The microimmunofluorescence test for Chlamydia pneumoniae infection technique and interpretation. J Infect Dis 2000; 181 (Suppl 3): 421-425.
8. Lawila A, Bloigu A, Nayha S, Hass J, Leinonen M, Saikku P: Chronic Chlamydia pneumoniae infection is associated with a serum lipid profile known to be a risk factor for atherosclerosis. Arterioscler Thromb Vasc Biol 1997; 17: 2910-2913.
9. DL Hahn, R Golubjatnikov: Smoking is a potential confounder of the Chlamydia pneumoniae-coronary artery disease association. Arterioscler Thromb 1992; 12: 945-947.